comparemela.com
Home
Live Updates
Apellis and Sobi report data from Phase II C3 glomerulopathy trial : comparemela.com
Apellis and Sobi report data from Phase II C3 glomerulopathy trial
Pegcetacoplan treatment resulted in sustained improvements in proteinuria and kidney function stabilisation.
Related Keywords
Caroline Baumal
,
Apellis Pharmaceuticals
,
Clinical Trials Arena
,
comparemela.com © 2020. All Rights Reserved.